{"nct_id":"NCT00546871","title":"Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2007-10-03","start_date_type":"ACTUAL","primary_completion_date":"2009-07-01","primary_completion_date_type":"ACTUAL","completion_date":"2009-09-01","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["TAK"]}